Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Moran

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
ACS Pharmacology & Translational Science|March 21, 2022
Novel Fluorescence-Based High-Throughput FLIPR Assay Utilizing Membrane-Tethered Genetic Calcium Sensors to Identify T-Type Calcium Channel ModulatorsYan-Ling Zhang, Sean P Moran, Andrew Allen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 28, 2018
M<sub>1</sub>-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognitionSean P Moran, Jonathan W Dickerson, Hyekyung P Cho, et al.
Elife|May 26, 2022
Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cellsWenyang Li, Jennifer Y Chen, Cheng Sun, et al.
ACS Chemical Neuroscience|September 13, 2016
Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M<sub>1</sub> PAM VU6004256Michael D Grannan, Catharine A Mielnik, Sean P Moran, et al.
Nature Cell Biology|September 8, 2020
lncRNA DIGIT and BRD3 protein form phase-separated condensates to regulate endoderm differentiationKaveh Daneshvar, M Behfar Ardehali, Isaac A Klein, et al.
Cell Reports|May 26, 2026
Srrm2 haploinsufficiency drives SynGAP-γ reduction, Agap3 mis-splicing, and oligodendrocyte deficits in a genetic mouse model of schizophreniaSameer Aryal, Chuhan Geng, Margaret A Yin, et al.
ACS Chemical Neuroscience|April 28, 2018
A Novel M<sub>1</sub> PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic ToxicityJerri M Rook, Jeanette L Bertron, Hyekyung P Cho, et al.
ACS Chemical Neuroscience|August 28, 2024
Discovery of VU6007496: Challenges in the Development of an M<sub>1</sub> Positive Allosteric Modulator Backup CandidateJulie L Engers, Katrina A Bollinger, Rory A Capstick, et al.
Neuron|September 1, 2023
Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant miceZohreh Farsi, Ally Nicolella, Sean K Simmons, et al.
Aging Brain|January 2, 2023
Cerebral Aβ deposition in an Aβ-precursor protein-transgenic rhesus monkeyAnthony W S Chan, In Ki Cho, Chun-Xia Li, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
ACS Pharmacology & Translational Science|March 21, 2022
Novel Fluorescence-Based High-Throughput FLIPR Assay Utilizing Membrane-Tethered Genetic Calcium Sensors to Identify T-Type Calcium Channel ModulatorsYan-Ling Zhang, Sean P Moran, Andrew Allen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 28, 2018
M<sub>1</sub>-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognitionSean P Moran, Jonathan W Dickerson, Hyekyung P Cho, et al.
Elife|May 26, 2022
Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cellsWenyang Li, Jennifer Y Chen, Cheng Sun, et al.
ACS Chemical Neuroscience|September 13, 2016
Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M<sub>1</sub> PAM VU6004256Michael D Grannan, Catharine A Mielnik, Sean P Moran, et al.
Nature Cell Biology|September 8, 2020
lncRNA DIGIT and BRD3 protein form phase-separated condensates to regulate endoderm differentiationKaveh Daneshvar, M Behfar Ardehali, Isaac A Klein, et al.
Cell Reports|May 26, 2026
Srrm2 haploinsufficiency drives SynGAP-γ reduction, Agap3 mis-splicing, and oligodendrocyte deficits in a genetic mouse model of schizophreniaSameer Aryal, Chuhan Geng, Margaret A Yin, et al.
ACS Chemical Neuroscience|April 28, 2018
A Novel M<sub>1</sub> PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic ToxicityJerri M Rook, Jeanette L Bertron, Hyekyung P Cho, et al.
ACS Chemical Neuroscience|August 28, 2024
Discovery of VU6007496: Challenges in the Development of an M<sub>1</sub> Positive Allosteric Modulator Backup CandidateJulie L Engers, Katrina A Bollinger, Rory A Capstick, et al.
Neuron|September 1, 2023
Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant miceZohreh Farsi, Ally Nicolella, Sean K Simmons, et al.
Aging Brain|January 2, 2023
Cerebral Aβ deposition in an Aβ-precursor protein-transgenic rhesus monkeyAnthony W S Chan, In Ki Cho, Chun-Xia Li, et al.
Pageof 3